INDUSTRY × Observational × Carcinoma, Transitional Cell × Clear all AVENANCE
Completed
596 enrolled 43 charts
JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study
Active not recruiting
360 enrolled
A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer
Not yet recruiting
3,000 enrolled
IMreal
Active not recruiting
2,756 enrolled
Evaluating Bladder CAREâ„¢, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases
Active not recruiting
80 enrolled
microDRIVE
Recruiting
1,000 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
CARAT
Recruiting
1,930 enrolled
HER2 and LA/mUC: A Multi-country Chart Review Cohort Study
Completed
389 enrolled
URADJ
Terminated
176 enrolled
Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER
Completed
400 enrolled
UMT-UC
Not yet recruiting
1,500 enrolled
A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread
Completed
79 enrolled 20 charts
A Multicenter Cancer Biospecimen Collection Study
Recruiting
1,650 enrolled
uTRACT
Recruiting
400 enrolled
A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China
Recruiting
482 enrolled
The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma
Unknown
148 enrolled
TRAVELER
Terminated
150 enrolled
PREVAIL
Completed
181 enrolled
Efficacy and Utility of Cxbladder Tests in Hematuria Patients
Unknown
684 enrolled
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Terminated
20 enrolled
Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma
Completed
1,170 enrolled
A Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in Argentina
Completed
13 enrolled
Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib
Terminated
2 enrolled
A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)
Completed
1,758 enrolled
PIONEER
Unknown
1,000 enrolled
A Study of Personalized Neoantigen Cancer Vaccines
Completed
93 enrolled
The Cxbladder Monitoring Study
Completed
803 enrolled
Announce
Terminated
22 enrolled
JONAS-1
Completed
200 enrolled
Evaluation Of Zetiq's Novel Cell Detect Technology For Detection Of Bladder Cancer In Urine Cytology
Unknown
500 enrolled